TGF-β may control the switch between tumorigenic growth and "stem cell/mesenchymal" potentially drug-resistant states

Jenna R. Bordelon, James M. Grichnik

Research output: Contribution to journalShort surveypeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)177-178
Number of pages2
JournalDermatologic Therapy
Issue number3
StatePublished - May 1 2015
Externally publishedYes


  • TGF-beta
  • differentiation
  • drug-resistance
  • epithelial-mesenchymal transition
  • melanoma
  • tumor stem cells

ASJC Scopus subject areas

  • Dermatology

Cite this